Circulatory System Nutritional, Metabolic, Endocrine Cardiology
Conditions
Interventions
Usual Care
Sponsors
Federal Medical Centre Abakaliki
Solix Pharmaceuticals and Healthcare Company Limited
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Ambulatory patients with a confirmed diagnosis of type 2 diabetes mellitus. 2. Patients on oral hypoglycemic therapy for over 6 months. 3. Patients resident within Abakaliki capital territory. 4. Patients with functional mobile phone numbers. 5. Patients who consented to the study orally.
Exclusion criteria
Exclusion criteria: 1. Patients who are pregnant. 2. Patients with secondary forms of hypertension. 3. Patients below 30 years. 4. Patients resident outside the Abakaliki Capital Territory urban settlement.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary clinical outcome measures chosen were a reduction in Glycated Haemoglobin A1c and Fasting Blood Glucose levels at the end of the study. The primary humanistic outcome measure chosen was improvement in the physical and mental domain scores of the short form - 12 health-related quality of life questionnaire at the end of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reductions in systolic blood pressure, diastolic blood pressure, total cholesterol, low-density lipoprotein cholesterol, triglycerides, 10-year risk of coronary heart disease and body mass index, as well as, an increase in high-density lipoprotein cholesterol, increase in the percentage of drug therapy problems identified and resolved at the end of the study. | — |
Countries
Nigeria
Contacts
Public ContactPaul Olisaemeka Ezeonu
Medical Director
Outcome results
None listed